Market cap
$1.04T
Price as of
2026-10-24
Latest filing
8-K · 2026-10-12
Alerts
8
Price$177.49 +29.22% 3M daily closessample
177.49136.20
2026-07-282026-08-192026-09-102026-10-012026-10-23
purchase / approvalsale / rejectionfiling / neutral
Latest events
Filings, trades, FDA; newest first- Oct 16INS
- Oct 12SEC
- Oct 06SEC
- Sep 25SEC
- Sep 21SEC
- Sep 11INS
- Sep 08INS
- Sep 02INS
Company facts
SEC EDGAR registration- Name
- Ascendis Pharma A/S
- Sector
- Healthcare
- Industry
- Biotechnology
- Smart-money score
- +32sample, -100 to +100
- Reporting currency
- USD
Who is positioning in ASND
sample- Insiders
- 32 insider transactions over 90 days, net selling, $428.4M
- Congress
- 5 members traded over 90 days
- Institutions · 13F
- 37 funds hold $11.4B
- Activists · 13D/G
- No 13D/13G activist filings on record
How are the fundamentals trending?
sample, by period endRevenue$29.2B +17.7% y/y
Q4 2024Q3 2026
Inventory$17.4B +11.7% y/y
Q4 2024Q3 2026
Accounts receivable$13.4B +18.0% y/y
Q4 2024Q3 2026
Total debt$34.2B +8.3% y/y
Q4 2024Q3 2026
Peers
sample- Sample peer A
- $809.5B -5.5% 3M
- Sample peer B
- $389.8B +0.2% 3M
- Sample peer C
- $945.1B +8.8% 3M
- Sample peer D
- $936.3B +0.7% 3M
- Sample peer E
- $806.6B +14.4% 3M